RBCC | Bulls Are Charging For Rainbow BioSciences Stock

RBCC Stock, Rainbow Coral Corp., Rainbow BioSciences LLC, hot penny stocksAfter being recognized as a revolutionizer of cellular research, the penny stock of Rainbow Coral Corp. (OTC: RBCC) has done the exact same to its investors. Up over 320% in the last 4 trading sessions, RBCC stock exploded itself onto the top 20 OTC stocks traded this morning and is showing no signs of pulling back. With their subsidiary, Rainbow BioSciences, having joined forces with n3D last year to help develop and market the Bio-Assembler, is big pharma eyeing the coral reef growers?

Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!

RBCC, RBCC Stock, OTC RBCC, RBCC Stock Quote, RBCC Stock Review, RBCC Stock Chart, Rainbow Coral Corp., Rainbow BioSciences LLC, hot penny stocks, hot OTC stocks, best OTC stocks, best penny stocks, penny stocks on the rise, OTC stocks on the rise, penny stock to watch, penny stock picks, Good Penny Stocks to Buy, OTC Stock Picks, penny stocks, RBCC Stock Quote

Market Cap: 5.12M
Last: 0.449 ▲ +0.159 (+54.83%)
Volume: 799,975
Dollar Volume: $322,097
Open: 0.29
Low: 0.29
Trades: 225
Authorized: 250,000,000
Issued and Outstanding: 11,407,328
14-Day Rel Strength: 78.45%
14-Day Stochastic: 90.27%

Looking for Hot Penny Stocks?
here To Receive FREE Penny Stock Alerts

Rainbow Coral Corp.’s biotech subsidiary, Rainbow BioSciences, has been on an extremely bullish platform thus far in 2013 declaring itself as one of the potentially lucrative new opportunities in the $232 billion personalized medicine market. After pulling in $76,808 in revenues for the nine months ended December 31, 2012 versus $57,180 for the same period in 2011, perhaps the most exciting aspect driving RBCC stock is the lack of any short or long term debt.

With innovation driving what’s expected to be a $452 billion market for personalized medicines in the U.S. by 2015 according to PricewaterhouseCoopers’ predictions, RBCC and their efforts to compete alongside companies such as Bristol Myers Squibb Co. (NYSE: BMY), Biogen Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) and Amgen Inc. (NASDAQ: AMGN) could be the bull that investors need to hear after effectuating the 1-for-20 reverse stock split last summer.

Considering that RBCC stock traded above the $2.50 level for the first half of 2012, watching for a strong drive back towards that amount will be as fun as watching a dolphin show while snorkeling or scuba diving around a coral reef this summer.

About RBCC Stock

Rainbow Coral Corp., through their wholly-owned subsidiary, Rainbow BioSciences, LLC, is focused on building a coral farm facility to develop and grow live coral, independent of the oceans, as a future farm reserve against the decline of natural wild reefs.

Click here to view the SEC filings for RBCC.
Click here to view the website for Rainbow BioSciences.

Last 5 Trading Sessions:

Date Last Change % Change Volume
05/07/13 0.2900 +0.0900 +45.00% 562,100
05/06/13 0.2000 +0.0650 +48.15% 584,100
05/03/13 0.1350 -0.0150 -10.00% 133,000
05/02/13 0.1500 unch unch 95,200
05/01/13 0.1500 unch unch 52,126


facebookTwitterStay Connected With Us: 

Bottom Line:

It sure looks like its all systems go for RBCC stock after converting an enormous amount of notes payable into tradeable shares during the course of 2012. RBCC stock could be a major player this summer and deserves a spot on the list of long penny stocks to watch. Waiting for a pull back of some sort towards the end of the week seems fitting considering the propulsion of momentum behind the PPS this week but might not be a guarantee considering the small share structure.

* Email

Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter

If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks

(We are 100% Anti-Spam and will never rent or sell your information)

Last updated by at .

  Recent Penny Stock News